Results 1 to 10 of about 181,282 (315)

MPTP: an industrial chemical and contaminant of illicit narcotics stimulates a new era in research on Parkinson's disease.

, 1987
Irwin J. Kopin
openalex   +1 more source

Predictive Value of Perivascular Space Network and Choroid Plexus for Levodopa Responsiveness in Parkinson's Disease. [PDF]

Eur J Neurol
Chen Z, Huang S, Liang Y, Cai D, Zhou X, He W, Xia J.   +6 more
europepmc   +1 more source

Disease-specific neuropathological alterations of the locus coeruleus in Alzheimer's disease, Down syndrome, and Parkinson's disease. [PDF]

Alzheimers Dement
Fructuoso M, Vermeiren Y, Boluda S, Stimmer L, Crans RAJ, Xicota L, Eisel U, Casan NO, Bun P, Duyckaerts C, Delabar JM, Strydom A, Van Dam D, Dierssen M, De Deyn P, Potier MC.   +15 more
europepmc   +1 more source

The global rise in Parkinson's disease: a critical analysis of causes and future directions. [PDF]

Front Public Health
Leon-Rojas JE.
europepmc   +1 more source

Editorial: The neuroscience of Parkinson's disease: exploring causes, symptoms, and potential treatments. [PDF]

Front Hum Neurosci
Germann J, Neumann S.
europepmc   +1 more source

Immune Cell Proteins and Parkinson's Disease: A Mendelian Randomization Analysis of Causal Associations. [PDF]

Brain Behav
Li H, He J, Xuan T, Gu S, Niu X, Ren Y, Zhan X, Cheng J.   +7 more
europepmc   +1 more source

Clinical and pharmacological problems of deprenyl (selegiline) treatment in Parkinson's disease

, 1983
G M Stern, Andrew J. Lees, R Hardie, M. Sandler   +3 more
openalex   +1 more source

Stressful life events and coping style in Parkinson's disease patients before the initial diagnosis. [PDF]

Front Psychol
Neumaier LS, Ouedraogo IR, Jost WH.
europepmc   +1 more source